Hedge Fund ValueAct purchased three million more shares of Valeant Pharmaceuticals (NYSE: VRX) making them the second largest share holder after Bill Ackman announced his withdrawal from the company. GreedyPicks announced a long position this week as well on StockTwits (@GoodGreed) on the basis of negative sentiment and a .40 price to sales ratio. The stock rose over 4% after hours on the news.
Bill Ackman capitulated his position in Valeant (NYSE: VRX) citing the enormous time and resources required to hold on.
USC study has concluded 9-15% of Twitter's active user base are bots, which is significantly higher than previously reported by the company last quarter.